SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-056989
Filing Date
2024-05-03
Accepted
2024-05-03 16:19:40
Documents
6
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242798-2_def14a.htm DEF 14A 710110
2 GRAPHIC lg_eyenovia-4clr.jpg GRAPHIC 27950
3 GRAPHIC ic_committeechair-bw.jpg GRAPHIC 1413
4 GRAPHIC ic_member-bw.jpg GRAPHIC 1341
5 GRAPHIC px_24eyenoviaproxy1pg1-bw.jpg GRAPHIC 306820
6 GRAPHIC px_24eyenoviaproxy1pg2-bw.jpg GRAPHIC 190391
  Complete submission text file 0001104659-24-056989.txt   1406834
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38365 | Film No.: 24913412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)